EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics

Alexander Klipp, Michael Burger, Jean-Christophe Leroux

Advanced Drug Delivery Reviews · 2023-09 · 200 · 115047

DOI: 10.1016/j.addr.2023.115047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-09. Verfasst von Alexander Klipp und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland. Electronic address: alexander.klipp@p…. Hauptthemen laut MEDLINE: Proteins, Cell-Penetrating Peptides. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Horizon 2020 Framework Programme, Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA therapeutics offer great potential to transform the biomedical landscape, encompassing the treatment of hereditary conditions and the development of better vaccines. However, the delivery of RNAs into the cell is hampered, among others, by poor endosomal escape. This major hurdle is often tackled using special lipids, polymers, or protein-based delivery vectors. In this review, we will focus on the most prominent peptide- and protein-based endosomal escape strategies with focus on RNA drugs. We discuss cell penetrating peptides, which are still incorporated into novel transfection systems today to promote endosomal escape. However, direct evidence for enhanced endosomal escape by the action of such peptides is missing and their transfection efficiency, even in permissive cell culture conditions, is rather low. Endosomal escape by the help of pore forming proteins or phospholipases, on the other hand, allowed to generate more efficient transfection systems. These are, however, often hampered by considerable toxicity and immunogenicity. We conclude that the perfect enhancer of endosomal escape has yet to be devised. To increase the chances of success, any new transfection system should be tested under relevant conditions and guided by assays that allow direct quantification of endosomal escape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteinsCell-Penetrating PeptidesHumansEndosomesTransfectionRNA, Small Interfering

Stichwörter der Autor:innen

Cell penetrating peptides (CPPs)Endosomal escapeEndosomal ruptureGene deliveryPhospholipasePore formationProtein-based endosomal escapeRNA therapeutics

Substanzen

ProteinsCell-Penetrating PeptidesRNA, Small Interfering

Autor:innen und Institutionen

  • Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland. Electronic address: alexander.klipp@pharma.ethz.ch.
  • Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland. Electronic address: michael.burger@pharma.ethz.ch.
  • Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland. Electronic address: jleroux@ethz.ch.

Förderung

  • European Research Council
  • Horizon 2020 Framework Programme
  • Horizon 2020

Zitieren

APA

Klipp, A., Burger, M., & Leroux, J. C. (2023). Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics. Advanced Drug Delivery Reviews, 200, 115047. https://doi.org/10.1016/j.addr.2023.115047

Vancouver

Klipp A, Burger M, Leroux JC. Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics. Advanced Drug Delivery Reviews. 2023;200:115047. doi:10.1016/j.addr.2023.115047

BibTeX
@article{Klipp2023,
  author = {Klipp, Alexander and Burger, Michael and Leroux, Jean-Christophe},
  title = {Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics},
  journal = {Advanced Drug Delivery Reviews},
  year = {2023},
  volume = {200},
  pages = {115047},
  doi = {10.1016/j.addr.2023.115047}
}
Kostenlos starten →